Hospitals or other medical facilities are particularly associated with the treatment of diseases and the idea of getting infected with a pathogen while being in the hospitals may be quite foreign to a lot of people. However, hospital infections or hospital-acquired infections affect a lot of people; for example, according to the World Health Organization, of every 100 patients that are hospitalized, at any given time, about 10 in developing and 7 in developed counties will acquire at least one hospital infection. In addition to this, newborns especially are at a higher risk of suffering from healthcare associated disease in emerging economies.
 |
| To learn more about this report: https://bit.ly/3mfxHN8 |
Some of the hospital infections are catheter-associated urinary tract infections, central line-associated blood stream infections, hospital-acquired pneumonia, surgical site infections, Clostridium difficile infections, and ventilator-associated pneumonia. Much like any other infection, the risk of hospital infections depends on the patient’s immune status. Other than this, prevalence of several pathogens in the local community and infection control practices are also major factors on which hospital infection depend. Some of the major risk factors for these infections include longer hospital stays, older age, multiple underlying chronic illnesses, recent invasive procedures, immunosuppression, frequent encounters with healthcare facilities, and mechanical ventilatory support.
Geographically, North America has emerged as the largest hospital infection therapeutics market in the past few years, which is attributed to the enhanced healthcare infrastructure, increased awareness regarding healthcare, high ratio of hospitals in comparison to the population, surging aging population, and rising count of multi drug resistant microbial pathogens in the region. Apart from this, the demand for hospital infection therapeutics is also expected to increase significantly in the Asia-Pacific region because of the rising incidence of hospital infections and high requirement for therapeutic drugs in countries including China and India.
In conclusion, the demand for hospital infection therapeutics is growing due to the rising incidence of hospital infections.
Read more: https://www.psmarketresearch.com/market-analysis/hospital-infection-therapeutics-market
No comments:
Post a Comment